Stephanie Dorman presented our paper, “Non-coding mutation analysis reveals previously unrecognized pathways in lymph node-invasive breast cancer,” (Abstract) at the Annual AACR meeting. The poster presentation was very well attended with more than 30 visitors, including representatives from several personalized medicine and genomics companies. Many of the attendees expressed interest in the Shannon human mRNA splicing mutation and Veridical platforms, which were used to generate the results given in this paper.
We find and validate mutations that others cannot